REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/10/2026
Back to search
Official data from USPTO
XOMAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
08/10/2026
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
05/13/2019
Registration date
08/10/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2021
Last transaction
08/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/02/2019
First use in commerce
10/25/2019
Drawing code
4
Owner type
03
Owner location
ROCKVILLE, MD, US
Examiner
HOWARD, PARKER WALDRIP
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PSOMAGEN, INC.
Macrogen Corp.
Representatives
Sang K. Park MOON, PARK & ASSOCIATES
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
DNA testing for scientific research purposes; DNA sequencing analysis for scientific research purposes; research and development of DNA chips; structural and functional analysis of genomes; multiple nucleotide sequence analysis for scientific research purposes; providing information relating to scientific analysis of the genetic information via online networks; advisory services relating to gene therapy products and clinical trials; biological information checkgenetic testing for scientific research purposes; biological information checkgenetic testing for medical research purposes; research in the field of gene analysis
Class 44
Genetic testing for medical and therapeutic purposes; provision of genetic information for medical and therapeutic purposes; analysis of human biodata for medical purposes; DNA screening for medical purposes; genetic counseling for medical purposes
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/09/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/08/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/25/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/25/2021
IUAF
USE AMENDMENT FILED
06/15/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/26/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/16/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/12/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/05/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/22/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2020
GNRT
NON-FINAL ACTION E-MAILED
10/16/2020
CNRT
NON-FINAL ACTION WRITTEN
10/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2020
GNRT
NON-FINAL ACTION E-MAILED
04/01/2020
CNRT
NON-FINAL ACTION WRITTEN
04/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2020
ALIE
ASSIGNED TO LIE
03/26/2020
NREV
NOTICE OF REVIVAL - E-MAILED
03/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2020
PETG
PETITION TO REVIVE-GRANTED
03/19/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
03/19/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
02/20/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/02/2019
GNRT
NON-FINAL ACTION E-MAILED
08/02/2019
CNRT
NON-FINAL ACTION WRITTEN
08/02/2019
DOCK
ASSIGNED TO EXAMINER
07/29/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/29/2019
NWAP
NEW APPLICATION ENTERED
05/16/2019
Continuous trademark protection
Get notified about every new filing that threatens XOMAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.